Chemoinformaics analysis of 5-epihexahydrocurcumin
| Molecular Weight | 374.433 | nRot | 10 |
| Heavy Atom Molecular Weight | 348.225 | nRig | 13 |
| Exact Molecular Weight | 374.173 | nRing | 2 |
| Solubility: LogS | -3.236 | nHRing | 0 |
| Solubility: LogP | 1.829 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 57.2186 |
| nHD | 3 | BPOL | 30.4234 |
| QED | 0.592 |
| Synth | 2.718 |
| Natural Product Likeliness | 1.083 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.039 |
| Pgp-sub | 0.994 |
| HIA | 0.045 |
| CACO-2 | -4.865 |
| MDCK | 0.000015 |
| BBB | 0.085 |
| PPB | 0.937182 |
| VDSS | 0.7 |
| FU | 0.0304972 |
| CYP1A2-inh | 0.618 |
| CYP1A2-sub | 0.95 |
| CYP2c19-inh | 0.67 |
| CYP2c19-sub | 0.625 |
| CYP2c9-inh | 0.637 |
| CYP2c9-sub | 0.89 |
| CYP2d6-inh | 0.754 |
| CYP2d6-sub | 0.922 |
| CYP3a4-inh | 0.594 |
| CYP3a4-sub | 0.496 |
| CL | 15.536 |
| T12 | 0.934 |
| hERG | 0.086 |
| Ames | 0.224 |
| ROA | 0.018 |
| SkinSen | 0.429 |
| Carcinogencity | 0.043 |
| EI | 0.155 |
| Respiratory | 0.058 |
| NR-Aromatase | 0.19 |
| Antiviral | No |
| Prediction | 0.757189 |